A Canadian biotech company automating RNA drug design with generative language models, aimed at neurodegenerative disease and the blood-brain barrier.
Nanil Therapeutics
Released June 27, 2025
Generative codon language model for mRNA design, trained on 338,417 coding sequences with inference-time masking that preserves the encoded protein.